| Authors: |
Lemelin A; Arthur JE Child Comprehensive Cancer Centre, University of Calgary, Calgary, Canada., Maj D; Arthur JE Child Comprehensive Cancer Centre, University of Calgary, Calgary, Canada. Electronic address: David.Maj@AlbertaHealthServices.ca., Takemura K; Department of Genitourinary Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Boyne DJ; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Canada., Warkentin MT; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Canada., Brenner DR; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Canada., Cheung WY; Arthur JE Child Comprehensive Cancer Centre, University of Calgary, Calgary, Canada; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Canada., Wells C; Arthur JE Child Comprehensive Cancer Centre, University of Calgary, Calgary, Canada., Labaki C; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA., McGregor BA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA., Contreras LM; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, USA., Pal SK; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, USA., Beuselinck B; Department of General Medical Oncology and Laboratory for Experimental Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium., McKay RR; Department of Oncology, Moores Cancer Center, University of California San Diego, La Jolla, USA., Szabados B; Barts Cancer Institute, Queen Mary University of London, London, UK., Powles T; Barts Cancer Institute, Queen Mary University of London, London, UK., Yuasa T; Department of Genitourinary Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Ludwig L; Ipsen Biopharmaceuticals Canada, Inc., Mississauga, Canada., Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA., Heng DYC; Arthur JE Child Comprehensive Cancer Centre, University of Calgary, Calgary, Canada. |
